Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Filings indexed 281 across all filing types
Latest filing 2026-05-11 Earnings Release
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Cda esamina i Ricavi consolidati al 31.03.2026
Earnings Release Classification · 85% confidence The document is a regulatory press release announcing the Board’s review of consolidated revenues for the quarter ended 31 March 2026, with high‐level Q1 revenue figures and commentary. It does not include full interim financial statements, but provides key highlights of quarterly results, consistent with an Earnings Release. Q1 2026
2026-05-11 Italian
Acquisto azioni proprie
Regulatory Filings
2026-05-08 Italian
Convocazione Assemblea azionisti e messa a disposizione documenti
Regulatory Filings
2026-05-05 Italian
Acquisto azioni proprie
Regulatory Filings
2026-04-30 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 95% confidence The document is a press release titled “INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE” detailing the weekly purchases of the company’s own shares under an authorized share buyback programme, including dates, quantities, prices, and resulting holdings. This is not a full annual or interim report but a specific notification of transactions in own shares. Under the categorization, this corresponds to Transaction in Own Shares (POS).
2026-04-24 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 94% confidence The document is a regulated market press release reporting the company’s purchase of its own shares under an authorized buyback program, including detailed daily volumes and prices. This is a classic ‘‘Transaction in Own Shares’’ disclosure (share repurchase), matching code POS.
2026-04-17 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.